Search research articles
Contact Us
Filters
Showing results (1-10 of 15) with videos related to
Page
of 2
Sort By:
The Journal of Pharmacy and Pharmacology
|
April 18, 2008
Effects of glycyrrhetinic acid and liquorice extract on cell proliferation and prostate-specific antigen secretion in LNCaP prostate cancer cells
Susan Hawthorne, Sandra Gallagher
Obstetrics and Gynecology
|
October 26, 2019
In Reply
Sandra Gallagher, Daniel Dugi
The Prostate
|
May 27, 2004
Amplification of MMP-2 and MMP-9 production by prostate cancer cell lines via activation of protease-activated receptors
Susan R Wilson, Sandra Gallagher, Kate Warpeha, et al.
Obstetrics and Gynecology
|
April 11, 2019
Implementation of a Pelvic Floor Physical Therapy Program for Transgender Women Undergoing Gender-Affirming Vaginoplasty
Da David Jiang, Sandra Gallagher, Laura Burchill, et al.
Journal of Clinical Medicine
|
November 26, 2016
Inebilizumab, a B Cell-Depleting Anti-CD19 Antibody for the Treatment of Autoimmune Neurological Diseases: Insights from Preclinical Studies
Ding Chen, Sandra Gallagher, Nancy L Monson, et al.
Molecular Immunology
|
February 17, 2017
CD47 limits antibody dependent phagocytosis against non-malignant B cells
Sandra Gallagher, Sean Turman, Kristen Lekstrom, et al.
Magnesium Research
|
June 1, 2007
Moderate magnesium deprivation results in calcium retention and altered potassium and phosphorus excretion by postmenopausal women
Forrest H Nielsen, David B Milne, Sandra Gallagher, et al.
Journal of the American College of Nutrition
|
May 31, 2007
Dietary magnesium deficiency induces heart rhythm changes, impairs glucose tolerance, and decreases serum cholesterol in post menopausal women
Forrest H Nielsen, David B Milne, Leslie M Klevay, et al.
Arthritis & Rheumatology (Hoboken, N.J.)
|
November 26, 2015
MEDI-551 Treatment Effectively Depletes B Cells and Reduces Serum Titers of Autoantibodies in Mice Transgenic for Sle1 and Human CD19
Sandra Gallagher, Isharat Yusuf, Tom M McCaughtry, et al.
International Immunopharmacology
|
May 11, 2016
Pharmacological profile of MEDI-551, a novel anti-CD19 antibody, in human CD19 transgenic mice
Sandra Gallagher, Sean Turman, Isharat Yusuf, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 15) with videos related to
Sort By:
Page
of 2
The Journal of Pharmacy and Pharmacology
|
April 18, 2008
Effects of glycyrrhetinic acid and liquorice extract on cell proliferation and prostate-specific antigen secretion in LNCaP prostate cancer cells
Susan Hawthorne, Sandra Gallagher
Obstetrics and Gynecology
|
October 26, 2019
In Reply
Sandra Gallagher, Daniel Dugi
The Prostate
|
May 27, 2004
Amplification of MMP-2 and MMP-9 production by prostate cancer cell lines via activation of protease-activated receptors
Susan R Wilson, Sandra Gallagher, Kate Warpeha, et al.
Obstetrics and Gynecology
|
April 11, 2019
Implementation of a Pelvic Floor Physical Therapy Program for Transgender Women Undergoing Gender-Affirming Vaginoplasty
Da David Jiang, Sandra Gallagher, Laura Burchill, et al.
Journal of Clinical Medicine
|
November 26, 2016
Inebilizumab, a B Cell-Depleting Anti-CD19 Antibody for the Treatment of Autoimmune Neurological Diseases: Insights from Preclinical Studies
Ding Chen, Sandra Gallagher, Nancy L Monson, et al.
Molecular Immunology
|
February 17, 2017
CD47 limits antibody dependent phagocytosis against non-malignant B cells
Sandra Gallagher, Sean Turman, Kristen Lekstrom, et al.
Magnesium Research
|
June 1, 2007
Moderate magnesium deprivation results in calcium retention and altered potassium and phosphorus excretion by postmenopausal women
Forrest H Nielsen, David B Milne, Sandra Gallagher, et al.
Journal of the American College of Nutrition
|
May 31, 2007
Dietary magnesium deficiency induces heart rhythm changes, impairs glucose tolerance, and decreases serum cholesterol in post menopausal women
Forrest H Nielsen, David B Milne, Leslie M Klevay, et al.
Arthritis & Rheumatology (Hoboken, N.J.)
|
November 26, 2015
MEDI-551 Treatment Effectively Depletes B Cells and Reduces Serum Titers of Autoantibodies in Mice Transgenic for Sle1 and Human CD19
Sandra Gallagher, Isharat Yusuf, Tom M McCaughtry, et al.
International Immunopharmacology
|
May 11, 2016
Pharmacological profile of MEDI-551, a novel anti-CD19 antibody, in human CD19 transgenic mice
Sandra Gallagher, Sean Turman, Isharat Yusuf, et al.
Page
of 2